ConductScience.org, home

Paper39137167

Oral resveratrol in adults with knee osteoarthritis: A randomized placebo-controlled trial (ARTHROL).

Nguyen C and 9 others. PLoS Med, 2024. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Oral resveratrol in adults with knee osteoarthritis: A randomized placebo-controlled trial (ARTHROL). Papers, record 39137167. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39137167

Download JSON
Disease
osteoarthritis, knee143 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Oral resveratrol in adults with knee osteoarthritis: A randomized placebo-controlled trial (ARTHROL).
PubMed
Journal
PLoS Med
PubMed
Year
2024
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
3.73, provisional
iCite
Revised in PubMed
2026-10-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nguyen CChristellehttps://orcid.org/0000-0001-7141-3230
2Coudeyre EEmmanuelhttps://orcid.org/0000-0001-5753-2890
3Boutron IIsabellehttps://orcid.org/0000-0002-5263-6241
4Baron GGabriel
5Daste CCamille
6Lefèvre-Colau MMMarie-Martine
7Sellam JJérémie
8Zauderer JJennifer
9Berenbaum FFrancishttps://orcid.org/0000-0001-8252-7815
10Rannou FFrançois

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Osteoarthritis, KneeMajor topic
ResveratrolMajor topic
Humans
Male
Female
Middle Aged
Double-Blind Method
Administration, Oral
Aged
Treatment Outcome
Pain Measurement
France
Adult

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02905799Resveratrol in Knee OsteoarthritisResultsYes

Source ClinicalTrials.gov

Download CSV of trials

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130717015French and Mediterranean-style diets: Contradictions, misconceptions and scientific facts-A review.Food Res Int2019https://conductscience.org/library/papers/30717015PubMed
218759268The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production.Arthritis Rheum2008https://conductscience.org/library/papers/18759268PubMed
310765924
Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3.
Arthritis Rheum2000https://conductscience.org/library/papers/10765924PubMed
434174454
Comparative efficacy and safety of acetaminophen, topical and oral non-steroidal anti-inflammatory drugs for knee osteoarthritis: evidence from a network meta-analysis of randomized controlled trials and real-world data.
Osteoarthritis Cartilage2021https://conductscience.org/library/papers/34174454PubMed
530233159Efficacy and safety of co-administration of resveratrol with meloxicam in patients with knee osteoarthritis: a pilot interventional study.Clin Interv Aging2018https://conductscience.org/library/papers/30233159PubMed
618276737Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes.Rheumatology (Oxford)2008https://conductscience.org/library/papers/18276737PubMed
721484156Curcumin synergizes with resveratrol to stimulate the MAPK signaling pathway in human articular chondrocytes in vitro.Genes Nutr2011https://conductscience.org/library/papers/21484156PubMed
820924410The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis.Nat Rev Rheumatol2010https://conductscience.org/library/papers/20924410PubMed
919011540The action of resveratrol, a phytoestrogen found in grapes, on the intervertebral disc.Spine (Phila Pa 1976)2008https://conductscience.org/library/papers/19011540PubMed
1018606398Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis.Biochem Pharmacol2008https://conductscience.org/library/papers/18606398PubMed
1116632085Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable.J Pain Symptom Manage2006https://conductscience.org/library/papers/16632085PubMed
1224270963Body mass index, diabetes, and mortality in French women: explaining away a "paradox".Epidemiology2014https://conductscience.org/library/papers/24270963PubMed
1331278997OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.Osteoarthritis Cartilage2019https://conductscience.org/library/papers/31278997PubMed
1423328930Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway.Rheumatol Int2013https://conductscience.org/library/papers/23328930PubMed
1533383288Pain in women with knee and/or hip osteoarthritis is related to systemic inflammation and to adipose tissue dysfunction: Cross-sectional results of the KHOALA cohort.Semin Arthritis Rheum2021https://conductscience.org/library/papers/33383288PubMed
169101522Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III.J Rheumatol1997https://conductscience.org/library/papers/9101522PubMed
1720332509CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.BMJ2010https://conductscience.org/library/papers/20332509PubMed
1823376875Optimization of trans-Resveratrol bioavailability for human therapy.Biochimie2013https://conductscience.org/library/papers/23376875PubMed
199846848Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium.Am J Clin Nutr1998https://conductscience.org/library/papers/9846848PubMed
2028350759Resveratrol supplementation reduces pain experience by postmenopausal women.Menopause2017https://conductscience.org/library/papers/28350759PubMed

See all 47 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42942239Plant-Derived Polyphenols in Osteoarthritis: Mechanisms, Delivery Systems, and Therapeutic Synergy.Life (Basel)2026https://conductscience.org/library/papers/42942239PubMed
42941490Differential Expression of ACAN, COL1A1, and COL2A1 in Cartilage and Synovium During Osteoarthritis Progression: An Observational Pilot Study Supported by Preliminary Bioinformatic Analysis.J Clin Med2026https://conductscience.org/library/papers/42941490PubMed
42875481Emerging therapies for knee osteoarthritis.Nat Rev Rheumatol2026https://conductscience.org/library/papers/42875481PubMed
42859207Deciphering the mechanisms of resveratrol in knee osteoarthritis treatment: insights from bioinformatics and experimental validation.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42859207PubMed
42225637Exploring mitochondrial functions and dysfunctions in chondrocytes: toward the identification of novel therapies for osteoarthritis.Bone Res2026https://conductscience.org/library/papers/42225637PubMed
42018663Cyclodextrin-Epichlorohydrin-Cyanoguanidine Polymer for Resveratrol Delivery to Enhance Human Chondrocyte Function in Cartilage Repair.Biomacromolecules2026https://conductscience.org/library/papers/42018663PubMed
41588481Therapeutic Potential of Resveratrol in Cancer and Neurodegenerative Disorders: A Current Review.Biofactors2026https://conductscience.org/library/papers/41588481PubMed
41037125Resveratrol supplementation improves functional performance in knee osteoarthritis by upregulating sirtuin 1: a randomized study.Inflammopharmacology2025https://conductscience.org/library/papers/41037125PubMed
41009494Recent Developments in Osteoarthritis Research: Innovative Therapeutic Approaches and the Role of Polyphenols and Nanotechnology.Int J Mol Sci2025https://conductscience.org/library/papers/41009494PubMed
40995602Natural products in the treatment of osteoarthritis: Current status and prospects.J Orthop Translat2025https://conductscience.org/library/papers/40995602PubMed
40692773Pharmacological Mechanisms and Therapeutic Potential of Resveratrol in Rheumatoid Arthritis.Drug Des Devel Ther2025https://conductscience.org/library/papers/40692773PubMed
40502812Resveratrol: Molecular Mechanisms, Health Benefits, and Potential Adverse Effects.MedComm (2020)2025https://conductscience.org/library/papers/40502812PubMed
39519419Bioactive Compounds and Their Chondroprotective Effects for Osteoarthritis Amelioration: A Focus on Nanotherapeutic Strategies, Epigenetic Modifications, and Gut Microbiota.Nutrients2024https://conductscience.org/library/papers/39519419PubMed
39519204Bioactive Compounds in Osteoarthritis: Molecular Mechanisms and Therapeutic Roles.Int J Mol Sci2024https://conductscience.org/library/papers/39519204PubMed
39408977Inhibitory Effects of Reynoutria japonica Houtt. on Pain and Cartilage Breakdown in Osteoarthritis Based on Its Multifaceted Anti-Inflammatory Activity: An In Vivo and In Vitro Approach.Int J Mol Sci2024https://conductscience.org/library/papers/39408977PubMed

Download CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
RESVERATROLCHEMBL165Results1https://conductscience.org/library/drugs/CHEMBL165

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39137167

GET https://conductscience.org/api/papers/v1/39137167/references?page=2